Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma

BACKGROUND: Preclinical studies suggest that chemotherapy may enhance the immune response against pancreatic cancer. METHODS: The levels of granulocyte macrophage-colony-stimulating factor (GM-CSF) and interleukin-6 (IL-6) and the associated inflammatory marker C-reactive protein (CRP) were assessed...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Cancer
Главные авторы: Middleton, Gary, Greenhalf, William, Costello, Eithne, Shaw, Victoria, Cox, Trevor, Ghaneh, Paula, Palmer, Daniel H, Neoptolemos, John P
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2016
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782200/
https://ncbi.nlm.nih.gov/pubmed/26931369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.468
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы